ArticleTranslational cancer research2020

CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer.

Jordi Remon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.